Showing 1-10 of 43 results for "".
- Steven Leon, MA, PA-Chttps://practicaldermatology.com/profiles/steven-leon-ma-pa-c/La5v9M/
- Steven Leon, MS, PA-Chttps://practicaldermatology.com/profiles/steven-leon-ms-pa-c/O96g50/
- South Beach Symposium to Kick Off March 1https://practicaldermatology.com/news/south-beach-symposium-to-kick-off-march-1/2457895/Now celebrating its 16th year, the 2018 South Beach Symposium (SBS) will feature live demonstration workshops of minimally invasive aesthetic treatments with injectables and devices providing attendees with new skills and techniques that can easily be adapted to their current practice. Under the di…
- ABOUT PRACTICAL DERMATOLOGYhttps://practicaldermatology.com/pages/about-practical-dermatology/Practical Dermatology® is a monthly publication that provides coverage of medical care, cosmetic advancements, and practice management for clinicians in the field. With straight-forward, how-to advice from experts in various fields, we strive to enhance quality of care and improve the daily ope…
- Sally S. Leong, BShttps://practicaldermatology.com/profiles/sally-s-leong-bs/jPw3Ny/
- Leon Kircik, MD, FAADhttps://practicaldermatology.com/profiles/leon-kircik-md-faad/L09oqo/
- Leonel Hernandez Aya, MDhttps://practicaldermatology.com/profiles/leonel-hernandez-aya-md/La5vRV/
ICD-10: When the Rubber Meets the Road
https://practicaldermatology.com/topics/practice-management/icd-10-when-the-rubber-meets-the-road/18632/When plans to move to ICD-10 were first announced, providers expressed concerns about potential logistical concerns with the new coding system. However, now that the new system is in regular use, Leon Kircik, MD said health claim denial rates have been lower than expected and the transition has beenNew Topical Options for Psoriasis
https://practicaldermatology.com/topics/psoriasis/new-topical-options-for-psoriasis/19979/Leon Kircik, MD shares his excitement about new molecules for psoriasis. He discusses the available data for tapinarof, a first-in-class small-molecule topical therapeutic aryl hydrocarbon receptor (AhR)–modulating agent, and roflumilast cream, a once-daily topical formulation of roflumilast, a highCOVID and Biologics
https://practicaldermatology.com/series/dermatology-education-foundation/covid-and-biologics/19981/Is it safe to continue biologic therapies amid the COVID-19 pandemic? Are vaccines safe for these patients? Leon Kircik, MD talks about why he tells his patients to continue to use their medications and encourages them to get the COVID vaccine.
- Prev
- Next